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1. Introduction 
The mammalian CNS relies upon the ancient, innate immune system, to provide defence 
against attack by pathogens (virus, bacteria, fungi and parasites) and the clearance of both 
neurotoxic proteins and apoptotic cells. The main function(s) of the CNS innate immune 
system can be summarised as the detection of “non self”(pathogens) and “ altered self “ 
(neurotoxic proteins and apoptotic cells), with their subsequent clearance, designed to 
facilitate tissue repair and rapid return to normal function. The failure to express an 
effective protective response to detect and remove a pathogen (non –self) prolongs the 
innate immune response and this is associated with autoimmunity, chronic inflammatory 
diseases (Multiple sclerosis) and neuro degeneration (Alzheimer’s and Prion disease) 
(Hauwel et al., 2005 Griffiths et al., 2009). The failure to detect and clear apoptotic cells 
results in their accumulation and subsequent release of neurotoxic proteins and enzymes, 
contributing to excessive tissue damage (Griffiths et al., 2009).  
2. The blood brain barrier and immuno privilege 
Insects, have a brain lymph barrier, whereas, the vertebrate blood brain barrier (BBB) 
evolved 50-100 million years before the appearance of the adaptive immune system (Abbot 
1995; Lowenstein 2002). For this reason, the CNS immune response against pathogens relies 
upon the ancient and highly conserved innate immune system that first appeared in limited 
form in the Agnatha, 500 million years ago and almost 100 million years before the 
emergence of the systemic adaptive immune system in bony fish. (Lowenstein 2002). The 
vertebrate type BBB, was therefore present, long before the adaptive immune system and 
this barrier provide some immunoregulatory control of the CNS response to pathogens 
(Abbot 1995; Lowenstein 2002).  
Other protective physical barriers, are the choroid plexus between the systemic circulation 
and ventricular CSF (cerebro spinal fluid) and the specialized, ciliated ependymal (glia) 
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layer, that lines ventricles containing the CSF(Martino et al., 2001). Both these epithelial 
layers express highly conserved receptors that are able to detect pathogens in the CSF and 
regulate intra CSF inflammation (McMenamin., 1999; Laflamme and Rivest 2001; Canova et 
al., 2006; Rivest 2009).  
The presence of a BBB composed of endothelial cells linked by tight junctions and 
surrounded by astrocyte foot processes (Pachter et al., 2003) contributed to the development 
of homeostatic systems to preserve CNS electrolyte and hydrostatic pressure gradients 
(Abott 1995). To some extent, this also prevented infiltration into the brain by systemic cells 
(lymphocytes, myeloid related cells) of the more recent adaptive immune system and 
provided some evidence of immuno regulatory function. Once the vertebrate BBB had 
developed, the brain relied upon the resident glia and neurons (also perivascular cells and 
choroid plexus) to deliver the CNS immune response against pathogen invasion 
(Lowenstein 2002).  
To reflect this function, the resident glial cells have been termed” amateur ”innate immune 
cells, in contrast with the” professional” innate immune system cells such as macrophages, 
dendritic cells and natural killer cells (Hauwel et al., 2005).  
3. The CNS innate immune response involves detection of “ non self” and 
clearance of dangerous pathogens, neurotoxic proteins and apoptotic cells 
The cells responsible for delivering the CNS innate immune response are microglia, 
astrocytes, endothelial cells, ependymal cells and to a lesser extent neurons (Rivest 2009). Of 
great importance, is the capacity of these cells to discriminate between” non –self”defined 
by pathogens and “altered self “ (apoptotic cells and dangerous proteins)from “self “ (host 
cells) (Takeuchi et al., 2010; Elward and Gasque 2003). This discrimination relies upon the 
expression by microglia and the other glia of ancient, highly conserved, pattern recognition 
receptors PRR (TLR, RLR, NRL) that are localized upon the cell membrane, within 
endosomes and also released in soluble form (Jane way 1992; Kawai and Akira 2010).  
PRR, are able to detect unique, pathogen associated molecular patterns or PAMPs as 
represented by bacterial cell wall constituents, such as lipopolysaccharide (LPS). (Medzithov 
and Janeway 200). This property of the PRR is important for the danger theory as proposed 
by Matzinger; that while the immune system distinguishes between “self “and “non –self”, 
it also must discriminate dangerous from non -dangerous signals (Matzinger 1994). 
Endogenous molecules such as S-100 proteins (Foell et al., 2007) and high mobility box 
group I (HMBG1) (Bianchi 2007; Castiglioni et al., 2011) are released during non -apoptotic 
cell injury and initiate host tissue inflammation: they are regarded as either “alarmins” or 
”danger signals “and are identified by the PRR of the innate immune system, because they 
express, damage associated molecular patterns or DAMPs (Klune et al., 2008; Biannchi 
2007).  
Apoptotic cells express a range of “altered self “molecules on their surface, so called apoptotic 
cell associated molecular patterns or ACAMPs (Elward and Gasque 2003; Gregory and Devitt 
2004; Griffiths et al., 2009). The detection of “ altered self” by PRR as defined by DAMPS and 
ACAMPs, results in the activation of signalling pathways composed of intra cellular adaptor 
proteins regulating the expression of pro inflammatory cytokines such as the interferons 
(INFinterleukins(IL) and tumour necrosis factor (TNF (Griffiths et al 2009).  
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Scavenger receptors (SR), Mannose macrophage receptor (MMR), CD14, CD36, CD91(2 
macroglobulin or LRP low density lipoprotein receptor) and phosphatidylserine recepotor 
(PRS) are present on the host cell membrane or intracellular endosomes. These receptors are 
multifunctional because they detect PAMPS, ACAMPs and DAMPs to initiate engulfment 
and phagocytosis of pathogens or apoptotic cells (Stahl and Ezekowitz., 1998. Fadok et al., 
2000 and b, Hanayama et al., 2002; Gregory and Devitt 2004; Mukhopadhyay et al., 2004.) 
The resident cells of the CNS express two of the three complement pathways(CP) the 
classical and alternative, but not the lectin activated pathway (Gasque P et al., 2000; Morgan 
and Gasque 1996). The first complement component, C1q, functions as a PRR, a property 
shared with a wide range of other C lectins including, mannan binding protein (MBL) and 
the pentraxins; all these molecules are able to function as both opsonins and PRR capable of 
detecting PAMPS and ACAMPs. (Tenner AJ 1999; Lu et al., 2002;  Thielens et al 2002; Ogden 
et al., 2005).  
After binding to either an apoptotic cell (by detecting ACAMPS) or bacteria (through 
PAMPS), the opsonins provide a signal on a phagocytic cell that enhances phagcoytosis, 
either through activation of the complement C pathway or facilitating binding to a PRR such 
as the 2 integrin, CR3/CR4, receptors (Ehlers et al., 2000; Gasque et al 2000; Gasque 2004). 
Phagocytosis of opsonized pathogens, neurotoxic proteins and apoptotic cells by microglia 
and macrophages will promote a reduction in local inflammation (non -phlogistic response) 
stimulating the recruitment of stem cells from a distance niche and assisting tissue repair 
(Griffiths et al., 2009).  
4. Regulatory pathways prevent an uncontrolled innate immune response; 
the Neuro immuno-regulatory molecules (NIRegs) 
The uncontrolled activation of the innate immune response results in the production of 
neurotoxic factors and unregulated inflammatory cytokine release. These two factors 
contribute to any indiscriminate bystander damage and the amplification of underlying 
disease state. For this reason, the innate immune response must be regulated in order to 
prevent bystander neuron loss and an uncontrolled inflammatory response. There is now 
evidence of a group of neuro immuno regulatory (NIRegs) molecules, that by analogy are 
similar to T reg lymphocytes (Griffiths al., 2007; Hoarau et al., 2011). These T cells are 
responsible for regulating /controlling the innate immune response and for shaping the 
resident cells towards a protective phenotype. Several NIRegs, CD47 and CD 200, are 
capable of acting as “don’t eat me “signals allowing host cells to evade detection and 
phagocytosis by microglia and macrophages (Elward and Gasque 2003; Barclay et al., 
2002; Brown and Frazier., 2001; Hoek et al., 2000). The Siglecs, a family of lectins, also 
detect cells expressing “don’t eat me” signals in the form of sialic acid containing 
molecules (Crocker and Varki 2005). Pathogens do not generally express sialic acid 
residues and the absence of sialic acids provides a “ non -self “ signal, sometimes referred 
to as an “eat me signal “and this is detected by lectins, including Siglecs, and complement 
proteins.  
The CP is also strictly regulated by a series of complement regulatory proteins CRP (FH, 
CD55, CD46) preventing inappropriate activation and host destruction (Elward et al., 2005; 
Griffiths et al., 2009; Zipfel et al., 2009). Furthermore, components of the CP including C3a, 
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are also capable of recruiting stem cells into areas of tissue damage and increasing growth 
factor expression, both facilitating tissue repair (Griffiths et al., 2010).  
5. Toll like receptors (TLRs) are PRR with multiple roles in infection including 
pathogen detection and inflammatory response 
The TLR are an ancient, highly conserved family of PRR, which belong to the type-1 trans 
membrane receptors. They are characterized by a cytosolic C-terminal signalling domain –
Toll/interleukin -1receptor (TIR) required for intracellular signal transduction and terminal 
LRR(leucine rich repeats) domain that mediates the recognition of PAMPs (Kawai and Akira 
2010). This family of PRR are vital for the detection of PAMPs, including cell wall 
lipoproteins and nucleic acids, derived from bacteria, viruses, parasites and fungi (Iwaski 
and Medhitov 2010).  
TLR 4, or heterodimers TLR2-TLR1, TLR2-TLR6 and TLR5 (but notTLR3) binds to a ligand 
such as a PAMP or DAMP, the complex is internailized within the endosome and this 
triggers intracellular transduction pathways by recruiting the TIR interaction domain that 
forms multimers with, a number of adaptor proteins such as myeloid differentiation 
primary response protein, My D88, My D88 adaptor like (Mal, also TIR domain containing 
adaptor protein, TIRAP), TIR domain containing adaptor inducing IFN–(TRIF) and TRIF – 
related adaptor molecule TRAM. Activation of TLR by PAMPS recruits one of the above 
adaptor molecules and activates the My D 88 dependent pathway with NF- kB activation. 
An alternative signalling pathway following TLR binding to a ligand involves the activation 
of the TRIF –dependent pathway, with the induction of the type I interferon (anti -virus) 
response, with the expression of IFNand inflammatory cytokines (Netea et al., 2004 
Creagh and O Neill 2006).  
Mice deficient in the individual TRL negative regulatory proteins, such as zinc finger 
proteins, autophagy related molecules and ubiquitin are unable to regulate the 
inflammatory response subsequent to TLR ligand binding. This uncontrolled inflammatory 
response results in multi organ inflammation such as, chronic inflammatory bowel disease 
and auto immune arthritis. Conversly, MyD 88 deficiency reduces inflammation (Kwai and 
Akira 2010 for detailed discussion).  
A detailed review of the intra cellular signalling pathways linked to TLR activation by viral 
nucleic acids, bacterial lipo proteins and other ligands, with subsequent inflammatory 
cytokine synthesis is outside the scope of this review, but see Takeuchi and Akira 2007; 
Iwaski and Medhitov 2010; Kawai and Akira 2010) 
5.1 TLR act in combination with other PRRs and not always alone 
Interestingly, TLR2, forms hetero dimers with TLR-1 and this combination is able to detect 
Gram negative bacteria, whereas the heterodimer TLR-2-TLR-6 combination recognizes 
Gram positive organisms. Further cooperation between TLR -4 and the SR co -receptors, 
CD14 and CD36, together with the C lectin receptor, dendritic cell –specific intercellular 
molecule -3 grabbing non –integrin (DC –SIGN), detects glucuronoxylmannans found on the 
cell wall of fungi (Kumar et al 2010).  
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5.2 TLR distribution in the CNS 
Ten functional TLRs have been identified in humans, of these, nine are conserved in both 
humans and mice. In the human and mouse CNS, TLR 3, , TLR 7 and TLR 8 are located on 
the cell surface of neurons (Bisibi et al., 2002; Prehaud et al., 2005; Jackson et al., 2006), 
microglia (Alexopoulou et al., 2001; Olson et al., 2004; Jack 2005), astrocytes (Bsibi et al., 
2001; Bisibi et al 2006 Farina et al., 2005; Rivieccio et al., 2006; Carpentier et al., 2007) 
ependyma and oligodendrocytes (Bsibi 2002). TLR 7 and 8 on microglia (Olson et al., 2004), 
astrocytes (Buchiet al., 2008) neurons (Ma et al., 2006), TLR 9 on microglia (Mc Kimme et al., 
2006). Cells of the meninges, choroid plexus and circum ventricular organs are all exposed 
to the systemic circulation and express TLR 2 and TLR 4 (Lafalamme and Rivest 2001; 
Bowman et al., 2003; Laflamme et al., 2003;) see table1 
TLR, 3 TLR7, TLR8 and TLR 9 are distributed within intracellular organelles, endoplasmic 
reticulum, lysosomes and endolysosomes so they are strategically placed to detect intra 
cytoplasmic viral nucleic acids, both RNA and DNA (Griffin 2003; Kumar et al., 2011). 
Conversly, TLR2, TLR5 and TLR 6, are present on the cell surface and detect various 
bacterial components (Kumar et al., 2011; Iwasaki and Medzhitov 2010) 
TLRs11-13 have been described in neurons, astrocytes, ependymal and endothelial 
cells(Mishra er al., 2008). see table 1 
5.3 TLRs; Innate immune response to bacterial infection 
TLRs are expressed by glial and choroid plexus cells following bacterial infection (Bowman 
et al., 2003 Carpentier et al., 2008). TLR- 4 forms a complex with MD2 on the host cell surface 
and they provide the main Lipopolysaccharide (LPS), binding site. Further interaction 
between LPS binding protein with CD14, a glycophosphatidylinositol protein (GPI) with 
leucine repeat protein, delivers LPS to the TLR4-MD2 complex, this is internalized into 
endosomes and through the My88 protein intracellular signalling pathway eventually 
results in cytokine expression. TLR4 also detects virus envelope proteins and Streptococcus 
pneumoniae pneumolysin (Kwai and Akira 2010. Akira and Uematas., 2006).  
TLR2, is able to detect a wide range of bacterial wall PAMPS, including peptidoglycan, 
Mycobacteria (lipoarabinomannan mycobcateria), fungal (zymosan), haemagluttin on 
influenza virus, together with mucin molecules from Trypanosoma cruzei. The glucans are a 
main constituent of the fungal cell wall and in association with dectins -1(a C type –
lectin)are detected by the TLR2 receptor and internalized to produce a protective 
inflammatory response (Netea et al., 2004). TLR2 is not able to detect viral nucleic acids.  
TLR5 and TLR9 detect a different range of bacterial constituents; TLR5 recognizes the 
flagellin protein expressed by flagellated bacteria, whereas TLR9, detects bacterial and viral 
DNA, especially CpG DNA motifs, that are rarely found in mammalian cells (Kawai and 
Akira 2010). (see table 1). TRL 11, recognizes bacteria found in the genitourinary tract as 
well as a profilin, a molecule expressed by Toxoplasmosis gondii (Yarovinsky et al., 2005), and 
also neurocysticercosis (Mishra er al 2008).  
5.4 TLR; virus detection and the anti virus response 
TLR3 detects double stranded (ds) RNA formed during replication of RNAand DNA viruses 
(Alexopoulou et al., 2001; Wang T et al., 2004; Daffis et al., 2008) the viral nucleic acid binds 
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to N and C terminal sites on the TLR3 ectodomain activating the TRIF and NF- kB 
dependent pathways to produce an interferon type 1 anti- virus (IFN type -1) response (Paul 
et al., 2007) 
Conversly, TLR7 and TLR 9 detect single stranded viral (ss)RNA and DNA respectively, and 
signal through the adaptor protein (MyD88) to initiate intracellular signalling by activating 
transcription factors NF-kB and the interferon regulatory factors (IRFs).  
IRFs are translocated to the host cell nucleus where they regulate inflammatory cytokine 
synthesis and stimulate IFN type I interferon synthesis(IFNexpression) resulting in a 
protective response in adjacent cells, uninfected with a virus (Katze et al., 2002; Paul et al 
2007). IFNbinds to the IFN surface receptor (IFNAR) on an uninfected host cell leading to 
the activation of Janus kinases (JAK) with phosphorylation of transcription factors Signal 
Transducer and Activation of Signal (STAT1 and STAT2). These two proteins enter the host 
nucleus to drive the expression of IFN stimulated genes (ISGs)to intiate the anti virus host 
response.  
Many of the emerging RNA viruses responsible for encephalitis express viral proteins that 
inhibit the host’s innate anti -virus response by inhibiting specific steps in the pathway for 
IFN  synthesis, namely the ISGs and several anti -virus proteins blocking the hosts anti 
virus response (Type 1 interferon) (Griffin 2003; Paul et al., 2007) Examples of viruses and 
their individual proteins that block the host’s IFN expression include, West Nile Fever 
(Envelope protein E), Influenza (Non Structual protein -1), Ebola (VP 24, VP35) Rabies 
(Rabies virus phosphoprotein), Enterovirus (structural protein 3C).  
5.5 TLR detection of DAMPs in the absence of infection promotes inflammation 
Necrotic cells release a range of endogenous proteins such as, heat shock proteins (HSP), S -
100, High mobility group box 1 Interleukin (HMGB1), ATP and mitochondrial proteins that 
are all regarded as DAMPS, because they can initiate an inflammatory response. (Roth et al., 
2003; Lotze et al 2005; Krysko et al., 2010).  
Several PRR including TLR-3, TLR-7 and TLR-9 function as sensors of tissue necrosis 
(Cavassani et al., 2008; Marshak- Rothstein and Rifkin 2007). Chromatin –DNA and 
ribonucleoprotein complexes all of which contain “self”nucleotides that activate the 
intracellular PRRs, TLR 7and TLR 9, resulting in an autoimmune disease(Tian et al 2010). 
Self nucleic acids are usually unable to activate the innate immune system, but after 
degradation by serum nucleases they are detected by TLRs in endolysosomes resulting in 
a further inflammatory response (Cavassani et al., 2008) In Systemic lupus erythematosus 
SLE, (a chronic inflammatory multi-organ disease charachterized by antibody production 
against self antigens such as DNA). On this basis SLE is regarded as a typical autoimmune 
disease because serum auto antibodies bind to “ self” nucleic acids and are internalized by 
FcR IIIa receptors on DC. These complexes are detected by TLR7 and 9, leading to 
interferon type I response and persistent autoimmune inflammation (Marshak- Rothstein 
and Rifkin 2007).  
HMBG1 is an important DAMP, because it can bind to self DNA and pathogens. The 
receptor for activated glycation endproducts (RAGE) is also a PRR, and binds with HMBG1 
to form a complex. This is delivered to endosomes containing TLR9, activating both DC and 
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B lymphocytes, with an up regulation of inflammatory cytokines (Tian et al., 2007). The 
regulation of HMGBI is clearly an important factor contributing to reducing DAMP initiated 
inflammation. One regulator of this interaction is Thrombomodulin (CD141); it is expressed 
by microglia and has been shown to bind to HMBG before it can form a complex with 
RAGE, to prevent this complex being detected by TLR and promoting an inflammatory 
response. (Abeyama et al 2005).  
Heat shock proteins (HSP) and S-100, are important DAMPs and also interact with TLR 2-4 
/CD91 and the RAGE receptor. This complex also signals through the NF-kB pathway to 
activate proinflammatory cytokine expression (Foell et al., 2007; Yu et al., 2006). The 
regulation of DAMP initiated inflammation is not well understood; however two 
macrophage (and possibly microglial) related lectins, MINCL and Clec9A, both bind to 
ribonucleoproteins, SAP 130, released by necrotic cells preventing DAMPS binding to TLR, 
with a down regulation of cytokine expression (Sancho et al 2009).  
6. Non-TLR PRRs in pathogen detection 
6.1 RIG like receptor; RIG -1 and MDA5 receptors detect intracellular viral nucleic 
acids and initiate interferon synthesis 
Retinoic acid inducible agent -1 and melanoma differentiation associated gene 5 (MDA5) are 
both RIG-1 –like receptors (RLRs) , are helicases and signal through the adaptor molecule 
IPS-1 (Yoneyama et al., 2004; Kato et al 2006; Kwaki and Akiar 2010). They are expressed by 
microglia and astrocytes, and are located in the cytosol (Miranada et al., 2009). RLRs detect 
mainly virus RNA, both short and long ds and ss RNA (. Fur et al., 2008; Yoshida et al., 
2007) RIG-1 detects short double stranded RNA; negative sense single strand, Influenza A 
and Ebola viruses and positive sense single strand RNA, Japanese encephalitis and Hepatitis 
C (Yoneyama et al., 2004; Fuijita et al 2007., Mohamadzadeh et al., 2007) whereas, MDA-5 
detects cytoplasmic positive sense RNA, for example Poliovirus. (Griffin 2003; Kato et al 
2008) 
6.2 RiG-1 and MDA-5 anti virus response 
RIG-1 and MDA-5 contain caspase recruitment domains (CARDS) essential for down stream 
signalling and an intermediate DEeD/H-box RNA Helicase domain, essential for ligand 
binding and recognition. (Parisien et al., 2003) The interaction between the RIG-1 and MDA-
5 with nucleic acid from a pathogen activates the CARD containing adaptor (IPS-1) known 
as Cardif, MAVS and VISA, resulting in the up regulation of interleukins and a range of anti 
-virus proteins (Kumar et al 2010: Kato 2006) promoting the IFN type I response, capable of 
inhibiting viral replication(Paul et al 2007). See table 1. 
6.3 ND LR receptors; roles in the innate response against infection 
The NDLR (nucleotide –binding domain leucine rich repeat) are a group of highly 
conserved proteins found in diverse species, including sea urchins and humans. They 
(twenty two have been identified in humans and thirty four in mice) are a family of 
intracellular cytoplasmic PRR that represent sensors for detecting Gram negative and Gram 
positive bacteria, mycobacteria and DAMPs (Karaparakis et al 2007: ; Ting et al., 2010; 
Kumar et al., 2011).  
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These receptors are characterized by an N -terminal effector domain caspase recruitment 
domain (CARD), a centrally located nucleoside binding domain NACHT (or NOD) domain 
for nucleotide binding and a C terminal of leucine rich (LRR) mediating PAMP ligand 
recognition, e. g peptioglycan and flagellin in the bacterial cell wall (Sterka and Marriott 
2006: Kaparakis et al., 2007 Proell et al 2008).  
The actual process wherby an NLR detects either a PAMP or DAMP, is not understood. 
However, the C terminal LRR region recognizes PAMPS, but the crucial step in NLR 
activation is the oligomerization of NACHT domain and this permits binding to a series of 
intracellular adaptor proteins and eventually the intiation of IFN synthesis as the 
inflammatory response. (Proel2008)Further information about potential homo and 
heterotypical interactions between NLR s is needed to determine whether or not different 
combinations of NLRS demonstrate functional differences. Mutations in the genes encoding 
individual NLR have been linked to several chronic inflammatory disorders (such as 
Crohn’s disease and asthma) underlying the potential importance of NLR in human disease 
(Tinget al 2010).  
The expression of the NLR in the CNS is not clearly defined, although NOD 2 is expressed 
by monocytes, microglia and astrocytes (Chauhan et al; 2009) 
NOD1 and 2 are cytosol proteins, they are able to detect major components of bacteria cell 
walls, g –D glutamyl –meso –diaminopimelic acid (iE- DAP) present in numerous organisms 
including Listeria Bacillus subtilis, Shigella Flexneri, Campylobacter jejuni and, Helicobacter 
pylori; NOD-2 detects murmayl dipepetide from Salmonella Typhimurium, Mycobacteria 
tuberculosis, Listeria monocytogenes, Saphylococcus aureus and Neiseeria menigitidis 
(Sterka et al., 2006) Kumar et al 2011). Uncontrolled NOD-2 activation can, however, result 
in demyelinization, representing the detrimental effects of unregulated activation of the 
innate immune system against pathogen invasion. (Proell et al., 2008).  
NLR3, is a key component of NLR- 3 inflammosome (NLR 3, ASC and procaspase -1) 
because it is able to detect a wide range of PAMPs including viruses (adeno and 
influenzaviruses), bacteria (Staphylococcus aureus) and fungi (Candida albicans) (Osawa et 
al., 2010) and various DAMPs (HSP and BCL-2)(Schroder 2010). Of interest, is the 
association between a mutation in the nucleotide –binding oligomerization domain gene 
2(NOD2) and Crohn’s disease, an inflammatory bowel disease (Rehaume et al; ., 2010; Ting 
et al., 2010).  
The explanation for the role of NOD2 in some forms of bowel inflammation (Crohn’s 
disease) provides several insights into the more general immuno regulatory roles for NOD -
2. Firstly, as an activator of the transcription factor NF-kB, to increase cytokine synthesis, or 
as a negative regulator of the host TLR response to pathogens, thirdly, a capacity to increase 
host defence by up regulating the expression of small molecular weight (18-45 amino acids) 
molecules called the defensins in Paneth cells. The defensins assist with the intracellular 
lysis of phagocytosed bacteria, therfore regulating the severity of inflammation in the 
intestine wall (Rehaume et al., 2010).  
The precise mechanism by which intra cellular sensing of PAMPs, such as bacterial 
peptidoglycan derived molecules, meso –diaminopimelic acid and muramyl dipeptide is 
carried out is as yet, not known (Ting et al 2010). Once a PAMP or DAMP is detected by the 
NLR this activates the inflammasome pathway (a complex composed of NLR, the adaptor 
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ASC (apoptotic speck-containing protein) with a CARD and procaspase -1 increasing the 
expression of proinflammatory cytokines IL-and IL-18. (Royet et al., 2007; Hoarau et al., 
2011).  
The involvement of NLR in virus infection requires the mitochondrial located anti virus 
signalling protein, MAVS (also Cardif, IPS-1, VISA), that is responsible for type I interferon 
response. An NLR protein family member, NLRX1, regulates the interferon type 1 response 
by inhibiting the interaction between RIG-1 and MAVS, whereas NOD 2, also inhibits RNA 
virus production through its interaction with the anti- viral protein, 2-5 oligodenylate 
synthase type 2 (OAS2) (Ting et al 2010). see table 1.  
7. Scavenger Receptors (SR) detect pathogens, apoptotic cells and 
endogenous proteins; vital components of the innate immune response 
7.1 CD14, CD36 and SCARB 
CD14 is expressed by microglia and is both a membrane anchored 
glycophosphatidylinositol protein (GPI) and soluble PRR. It has a co-operative interaction 
with TLR- 4 to facilitate bacterial LPS detection and it interacts with apoptotic lymphocytes, 
via the intercellular adhesion molecule(ICAM-3) to facilitate their phagocytosis (Gregory 
2000). Clearance of apoptotic cells by CD14, depends upon detection of ACAMPS and this is 
also an anti -inflammatory response, reducing tissue damage, because the soluble form 
CD14 switches off activated T cells (Pender 2001).  
7.2 Scavenger receptors class A (SRAI, SRABI/II) and class B, CD36 
The best characterised SR is CD36, a multifunctional receptor, expressed by microglia and 
astrocytes (Husemann etal., 2002). It is able to bind to phosphatidyl (PS) and oxidized low 
density lipoprotein, both present on apoptotic cells (as ACAMPs) as well as neurotoxic 
proteins such as A4 (Ren et al., 1995; Coraci et al., 2002). Macrophage, CD36, co-operates 
with the vitronectin receptor v3 (CD51/CD61) to increase phagocytosis, because this 
complex recognizes the protein thrombospondin (TSP) located on the surface of apoptotic 
cells. (Lamy et al 2007: Fadok et al., 1998).  
A further receptor, Scavenger receptor B, SCARB (Lysosomal integral membrane protein II 
or CD36b like-2) is expressed by many different tissues and has also been identified as a 
receptor for the enterovirus EV71and coxsackie virus A16, although only EV71 is 
responsible for encephalitis. SCARB is expressed in most tissues, so it not possible to explain 
the neurotophic effect of EV71 as the result of this virus binding this new receptor. 
(Yamayoshi et al, 2009).  
7.3 CD91; a multi functional PRR 
The 2 macroglobulin LRP receptor-related or the lipoprotein low density lipoprotein 
receptor (CD91) is expressed by microglia and neurons (Marzolo et al., 2000), and functions 
as an entry receptor for both bacteria and viruses. HIV-1 utilizes CD91 as a docking receptor 
to enter the CNS via endocytosis; the toxin of the bacterium Pseudomonas is taken up by 
CD91 (Herz et al., 2001). Despite this evidence, the contribution made by this SR in 
defending against neuro infection is not yet clarified; CD91 is also able to bind toA4 
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amyloid and apoptotic cells (Marzolo et al., 2000). As the result of apoptosis, calreticulin, a 
soluble protein located on the endoplasmic reticulum migrates to the cell surface and 
becomes a potentially important ligand for phagocyte receptors, including mannan binding 
lectin (MBL), the first complement proteinC1q and the CD91 complex. (Ogden et al., 2001; 
Gardai et al., 2005) 
7.4 TREM -2; a new scavenger receptor 
Triggering receptor expressed by myeloid cells (TREM-2) and is an SR expressed on 
monocyte derived dendritic cells, osteoclasts and microglia (Takahashiet al., 2007). The 
TREM-2 receptor is expressed by microglia in conjunction with the receptor DAP-12 that 
shares many features with Draper, an ancient phagocytic receptor found in Drosphila. The 
microglial, DAP-12 receptor and Draper, both contain ITAM (immuno receptor tyrosine 
based activation motifs) and stimulation of this signalling pathway increases microglial 
phagocytosis and pro inflammatory cytokine expression. (Linnaetz et al., 2010). In vitro, 
microglia expressing TREM -2 demonstrated increased phagocytosis of membrane 
fragments from apoptotic neurons. This effect was also reproduced in experimental 
autoimmune encephalomyelitis(EAE)following the intravenous administration of TREM-2 
in bone marrow precursor cells and was accompanied by a down regulation of tumour 
necrosis factor (TNF). A loss of function mutation in both TREM-2 and Draper proteins are 
associated with a chronic neurodegenerative disease, Nasu-Hakola, characterized by the 
failure to clear neurotoxic proteins, representing a contributory factor in this form of early 
onset dementia (Colonna M et al., 2003). The TREM -2 mediated apoptotic response was 
inhibited by inflammatory signals activating the ITIM (immuno receptor tyrosine based 
inhibitory motifs) leading to the recruitment src homology 2 (SH) domains of syk protein 
kinases, preventing phagocytosis and down regulating both the microglial inflammatory 
and anti -pathogen responses.  
7.5 Lectins as PRR in the innate immune response to infection and injury 
The lectins are a range of carbohydrate binding proteins and glycoproteins, either homo 
or hetero oligomers of non -covalently bound, polypeptide units and carbohydrate 
recognition domains (CRD) that bind to a sugar molecule in a Ca 2+ dependent manner 
(Cambi et al., 2005). One important role for the lectins is to establish tolerance between 
bacteria living inside the host through molecular mimicry. Bacteria display surface lectin 
molecules similar to those present on host cells so bacterial lectins are detected as ” self “ 
by the host immune system, allowing them to remain in the gut with mutual benefit to 
both host and bacteria.  
The innate immune response also includes the C- type lectins (acting as PRRs) to detect 
PAMPS (Endo et al., 2006; Geijten beek et al., 2009). The most important families of lectins 
are the Pentraxins (extracellular), the Macrophage mannose receptor (MMR) located on the 
endoplasmic reticulum)(Stahl and Ezowitz 1998), the non classical C-type lectins, dectins 
1and 2, expressed by microglia (Brown G et al., 2006) Siglecs (cell membrane)(Crocker and 
Varki, 2001) and the newly identified C –type lectin member 4E (Clec4) (Sancho et al., 2009). 
The galectins, expressed by cerebral blood vessels, are an increasingly important family of 
lectins, functioning as a PRR to detect both intracranial l PAMPs and DAMPs (Sato et al., 
2009; Vasa, 2009).  
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7.6 MMR and DC-SIGN are PRR for “non self”, complex carbohydrates 
Glia, express trans membrane C- type lectins (Burundi et al., 1999) namely MMR (microglia, 
astrocytes and peri vascular cells) (Linehan et al., 1999) and DC- SIGN receptor that 
recognizes “self “intercellular adhesion glycoproteins ICAM. (van Kooyk et al., 2003). The 
DC-SIGN receptor is expressed by peri vascular cells and a population of dendritic cells, 
both associated with cerebral blood vessels (Mukhtar et al., 2002; Schwartz et al., 2002; 
Greter., 2005). MMR and DC- SIGN function as PRRs binding to and internalising viruses by 
endocytosis, promoting their degradation and antigen presentation to T cells in association 
with MHC (Stahl et al 1998; van Kooyk et al., 2003).  
Both, MMR and DC-SIGN, also recognize “non self” molecules containing a high mannose 
content (functioning as PAMPs), as found on enveloped viruses. Both MMR and DC-SIGN 
receptors provide a pathway for a virus to enter the CNS (le Cabec et al., 2005) and this is 
the case for Dengue (Miller et al 2008), HIV, Ebola and Marburg (both ss RNA Filo viruses), 
West Nile Fever virus (WNFV), Influenza A, all target MMR (Upham et al 2010.). Whereas, 
WNV and Ebola virus target the DC- SIGN receptor (Alvarez et al., 2002; Schwartz et al., 
2002; Mohameazah et al., 2007) 
7.7 Pentraxins 
The pentraxins are highly conserved proteins with a cyclic multimeric structure and include 
the acute phase reactant C protein (CRP) and serum amyloid protein (SAP). Microglia and 
neurons express CRP and SAP, both of which are capable of opsonising apoptotic cells with 
subsequent binding to the collectin, C1q, the first C pathway protein to stimulate 
phagocytosis. (Elward and Gasque 2003; Nauta et al 2003). CRP recognizes apoptotic cells 
through binding to phosphorylcholine found in oxidized lipids which are regarded as 
ACAMPs (Chang et al., 2002). Pentraxins, as opsonins, also initiate phagocytosis of 
apoptotic cells as they are capable of binding directly to microglial Ig (FcR) receptors and 
C1q (Chang et al 2002: Nauta et al., 2003) Despite this evidence, the contribution of the 
pentraxins to the removal of apoptotic cells from the CNS in neurodegenerative and 
inflammatory disease is yet to be defined.  
7.8 Galectins are lectins and PRR with multiple roles 
Most galectins are non – glycosylated, soluble proteins, distributed in most mammalian 
tissues, including the innate and adaptive immune systems (Sato et al., 2010: Vasta 2010). 
Glactins(previously known as S- type lectins) are expressed by cerebral vessel wall 
endothelium (Joubert et al., 1998). They are also examples of PRR capable of binding to 
viruses, bacteria (Streptococcus pneumonia, Neisseria meningitides, Haemophilus influenza and 
fungi Candida albicans, the protozoan Trypanosoma cruzi and parasite Toxoplasmosis gondii. 
Glactins are able to prevent Nipah virus entry in to endothelial cells by preventing virus 
fusion with ephrin B2 and B3 receptors on endothelial cell surface (Lo et al., 2010; Garner et 
al., 2010) However, this protective function of glactein is exploited by the HIV -1 virus, 
because it binds to glactin -1 and enters host cells. Organs that represent reservoirs for HIV-
1 infection express abundant glactin –1 on their cell surface, confirming glactins are “ non 
self” detecting PRR. (Sato 2009).  
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7.9 Defense collagens or collectins (MBL and SPA) 
These are soluble molecules expressed by the liver, lungs and astrocytes (Kuraya et al., 
2003; Wagner et al 2003)and include mannose binding lectin (MBL) and Lung surfactant 
protein A (SPA). Both these collectins are capable of recognizing carbohydrate patterns 
containing large numbers of mannose and fucose molecules characterized as PAMPs, and 
found in the cell wall of bacteria and viruses (non self), but not expressed by mammalian 
cells (Tenner AJ 1999; Elward Gasque 2003). The globular carboxyl C terminal of the 
defence collagen acts as PRR recognizes PAMPs and potentially ACAMPs, whereas the N 
-terminal domain links defence collagen to a receptor on phagocytic cells e. g microglia. 
MBL binds to Ebola and Marburg envelope gylco proteins, preventing these viruses 
gaining “subversive “entry to the host cell through the DC –SIGN receptor (Ji et al 2005). 
SPA and MBL are capable of binding to apoptotic cells and neutrophils, functioning as a 
bridging molecules, between the apoptotic cell and the phagocyte receptor CD91 
(Vandivier et al., 2002).  
7.10 Siglecs detect sialic residues as markers of “self” 
Siglecs (sialic acid –binding immunoglobulin like lectins) are a subgroup of the Ig super 
family, type 1 membrane proteins with an amino terminal V –set immunoglobulin domain; 
they represent a family of receptors that detect sialylated glycoproteins and glycolipids 
(Crocker and Varki 2001 Crocker etal., 2007). Two group of Siglecs can be identified; Siglecs 
common to mammals Siglec -1(sialoahesin, CD169) (Delputte et al., 2011), Siglec 2 (CD22), 
myelin associated siglec 4 and those Siglecs related to the CD33 family including siglec -10, 
11 and 16 (Lock et al., 2009 Mott et al., 2004). Most siglecs, are present on haemopoietic 
tissue however, sialoadhesin is expressed only on macrophages as a specific adhesion 
molecule, whereas siglec -11 is expressed by microglia (Angata et al., 2002). The CD33 
family of siglecs are expressed on most mammalian cells, with each siglec having a unique 
specificity for a sialylated ligands (sialic acid), so there is room for overlapping functions 
within the family of Siglec receptors (Cao and Crocker 2010). Their main function is the 
detection of “self “ indicated by sialic acid residues and the suppression of inappropriate 
microglial directed host cell phagocytosis.  
7.11 Complement system provides first line defence against pathogens PAMPS, 
DAMPs and ACAMPs 
The C system is an extremely ancient component of the innate immune system. It is thought 
to have evolved 300 million years ago, as part of the coagulation protein pathway. The 
complement system comprises of three pathways, the classical, alternative and lectin 
activated pathways. (Sjoberg et al., 2008; Gasque 2004; Gasque et al., 2000) 
The first component of the classical C pathway, C1q, has a multimeric structure, that 
represents a PRR and is expressed by astrocytes and neurons (Gasque et al., 2000). C1q is 
able to detect a variety of pathogens, apoptotic cells and neurotoxic misfolded proteins 
(mutant Prions, fibrillary amyloid), antigen –antibody complexes and DNA (Nauata et al 
2002; Korb et al., 1997). The identity of the C1q receptor is not well defined, but candidates 
include, CD93, expressed by microglia or C1qRp (Dean et al 2000 Webster et al., 2002. ; 
Elward and Gasque 2003).  
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The activation of the classical C pathway generates two anaphylotoxins (C3a, C5a) 
responsible for recruiting inflammatory cells into areas of tissue injury, as welll as opsonins 
(iC3b and C3) and the cytolytic membrane activation complex (MAC). With regards to 
pathogens such as bacteria and fungi, the opsonins (C3b and iC3b) coat the pathogen 
making it a more attractive target for microglia expressing the 2 integrin (CR3 
/CR4)receptors (Akiyma and Mc Geer 1990: Ehlers 2000; Reichart et al., 2003). Apoptotic 
cells contain activated DNA and this enables C1q to directly bind to apoptotic cells, 
activating the classical C pathway with the generation of opsonins C3b and iC3b, again 
providing targets for phagocytosis by CR3 and CR4 to reduce host cell damage (Mevorach 
et al., 1998; Korb et al., 1997). There is also evidence that the Ficolins (lectins) bind to 
ACAMPs expressed by apoptotic cells, activate complement and generate the opsonin C3, 
facilitating phagocytosis (Matsushita., 2010) 
8. Neurodegeneration; The detection and clearance of Pathogen protein 
associated molecular patterns (PPAMPS) and innate immune system 
activation 
Neurodegeneration produces neuronal loss and is characterized by intra and extra 
neuronal accumulation of dangerous(neurotoxic) intrinsic proteins (fibrillary amyloid, 
mutant prions, synuclein, mutant tau) classified as PPAMPs(pathogen protein 
associated molecular patterns) regarded as a sub type of DAMPS. PPAMPs are detected 
by a range of PRRs with resulting proinflammatory cytokine expression (Wyss-Coray and 
Mucke 2002). During chronic CNS inflammation, the accumulation of endogenous protein 
aggregates is perceived by the innate immune system as “stranger” or “danger” signals 
(DAMPs). In AD, it has been suggested that a variety of glial related PRR (CD14, TLR, 
CD36, CD91) with opsonins(C 1q, iC3b, C3) derived from C activation contribute to the 
removal of A4amyloid fibrils ( Coraci et al., 2002: Elkhoury et al., 2003; Fassbender et al., 
2004; Alarcon et al 2005: Tahara et al., 2006; Landreth et al., 2009)The SR, CD36, facilitates 
the assembly of a heteromeric complex composed of CD36, TLR4 and TLR6 following 
binding to A 4 (Stewart et al., 2010). 
A┚ fibrils can activate microglia and astrocytes through TLR4 (together with CD14 and MD2 
in microglia), leading to the activation of downstream inflammatory response genes (Reed -
Geaghan et al., 2009; Walter et al., 2007; Chen et al., 2006: Lehnardt et al., 2003, Bamberger et 
al., 2003). This explanation is consistent with mice carrying a nonfunctional TLR4 crossed 
with a mouse model of AD (APP/PS1 double transgenic mice) having a lower level of 
inflammatory cytokines than wild type animals (Walter et al., 2007; Jin et al., 2008). A TLR4 
polymorphism was shown to be associated with protection against late-onset AD in an 
Italian population, suggesting that theTLR4–mediated innate immune inflammation could 
influence AD pathology (Minorettiet al., 2006). TLR2 also may be a sensor for fibrillar A┚ 
(Chen K et al., 2006; Jana et al 2008). Blocking TLR2 signaling with antibody or by 
knockdown of the receptor gene in vitro suggested that TLR2 stimulation by A┚ promotes 
neurotoxic inflammation. However, mice lacking TLR2 crossed with APP/PS1 transgenic 
AD mice were reported to show a delay in A┚ deposition and improved behavior on 
memory tests (Richard et al., 2008) These apparently contradictory functions of TLR could 
be due to differences in the cell types as well as signaling pathways that are engaged by the 
amyloid peptides and/or fibrils. (Tahara et al., 2006) 
www.intechopen.com
 
Recent Advances in Immunology to Target Cancer, Inflammation and Infections 
 
214 
NOD-like receptors (NLRs) are also involved in A-induced inflammatory response. In AD, 
A┚ oligomers and fibrils induce lysosomal damage and trigger NALP3, a member of the 
NLR family that is expressed in microglia (Halle et al., 2008) NALPs activate downstream 
signaling proteins, such as ASC and this will lead to caspase 1 activation and increased 
processing of proinflammatory mediators like IL-1┚ and IL-18.  
Fibrillary amyloid and aggregated forms of mutant prion protein are opsonized by 
complement components (C1q, C3) to promote clearance by macrophages and microglia 
CR3/CR4(Tenner 2001: Kovacs et al., 2004). In AD as the result of C1q binding to fibrillary 
A┚4, the C pathway is activated increasing C3 and C5 as part of the protective response 
promoting clearance of the amyloid plaque (Mc Geer et al., 1989; Jian et al., 1994; 
Eikelenboom et al., 2002); inhibition of the complement cascade increased amyloid plaque 
burden (Wyss Coray and Mucke., 2002). However, in the context of acute inflammation, 
microglia and astrocytes express complement and it is plausible C activation on myelin/ 
neuronal debris contributes to secondary brain injury. The formation of the MAC and non-
specific binding to host cells would cause bystander damage.  
In Huntington’s disease the expression of C1q, C3, iC3b and C4 is increased on microglia 
and astrocytes, C activation is also present in experimental models of ischaemia (van Beek et 
al., 2000; van Beek et al., 2001: Singhrao et al., 1999). Interestingly, administration of a C1q 
inhibitor C1-INH, resulted in neuron protection after experimental ischaemia, but its 
protective effect was interpreted as independent of C1q activation of the complement 
pathway (De Simoni et al., 2004).  
A further sensing system for A┚, is provided by RAGE (receptor for advanced glycation 
endproducts ) a PRR and trans membrane receptor of the immunoglobulin super family 
RAGE is expressed on the surface of microglia, astrocytes, vascular endothelial cells, and 
particularly on neurons (Fang F et al 2010). Several reports suggest that A┚ peptide as well as 
A┚ oligomers bind to RAGE and contributing to the activation of microglia and the production 
of proinflammatory mediator (Yan et al., 2006). RAGE is also suggested to play an important 
role in the clearance of A┚4 and to be involved in cellular processing and signaling (Origlia et 
al, 2008; Takuma et al 2009). The role of the SRs, CD36, CD14 and particularly CD91, in AD is 
ambiguous; studies indicate that CD91 has the capacity to influence both the production and 
the clearance of A┚. CD91 is a receptor for APP, apoE, and ┙2M, which all have been 
genetically linked to AD (. Bu, 2006). Clearance of A┚ complexed to these ligands could 
contribute to a reduction in amyloid plaque burden (Herz et al., 2001).  
8.1 Phagocytosis of apoptotic cells (altered self) reduces local inflammation (the non 
phlogistic response) 
Apoptotic cells result from the consquences of infection, ischaemic infarction and 
neurodegeneration; they express a range of apoptotic cell associated molecular patterns or 
ACAMPs on their surface. In general phagocytosis of apoptotic cells reduces local tissue 
inflammation, as the so called “non pholgistic response”, providing some degree of local 
immunoregulation. (Chan et al., 2001: Chang et al., 2001; Magus et al., 2002; Griffith set al., 
2009. The result of clearing apoptotic cells reduces local inflammation (non phlogistic 
response) and this is in contrast to the increase inflammatory response, following attempted 
clearance of pathogens (phlogistic response). The clearance of apoptotic cells by CD14 is 
anti-inflammatory (non phlogistic) as it binds to and switches off T cells (Gold1991), releases 
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the anti-inflammatory cytokines TGF┚ and prostaglandin E2, together with growth factors 
such as Vascular endothelial growth factor (VEGF), all reducing local inflammation and 
promoting tissue repair (Griffiths., 2009 et al, Golpon HA et al., 2004, Huynh et al., 2002, 
Voll R et al., 1997) 
ACAMPs include nucleic acids and sugars, the best characterized ACAMPs are, 
phosphatidyl serine (PS) and calreticulin (Fadok et al., 2000: Hoffman et al 2001; Gardai et 
al., 2005; Gardai et al., 2006).  
Glia and macrophages express PRRs that recognize ACAMPS, including the PS receptor 
(PSR), CD14 (in conjunction with ICAM), LRP, CD36, the soluble bridging molecules milk -
fat gobulin (MFG -EGF 8), growth arrest –specific gene 6, and TREM-2 (Prieto et al., 1999, 
Gregory 2000; Hanayama et al., 2002; Leonardi –Essman et al., 2005 Gardaiet al., 2006). 
Thrombospondin, a protein expressed by glia, acts as a bridging molecule between an as yet 
undefined ligand on the apoptotic cell and CD36, to promote phagocytic clearance (Lamy et 
al., 2007). PS on apoptotic cells and IgM both bind to C1q to activate C pathway and opsonin 
(C3b iC3b) synthesis, to provide targets for CR3 and CR4 (Kim et al., 2002).  
Animals deficient in C1q accumulate apoptotic cells, resulting in glomerulonephritis and an 
(SLE)- like disease, because the accumulated DNA and RNA both function as DAMPs and 
trigger autoimmune inflammation (Botto et al 1998). Activated microglial and Kolmer cells 
in the choroid plexus (Singhrao et al., 1999) express C3R /CR4 and both detect C1q, C3b, 
C3b as well as MBL, underlining the importance of glia for removing apoptotic cells 
opsonised with C from the CSF (Mevorach et al., 1998; Reichart et al., 2003). The lectins, 
Ficolins and MBL, are capable of interacting with ACAMPs such as calcireticulin, to initiate 
clearance of apoptotic cells (Ogden et al., 2001).  
Phagocytes involved in apoptotic cell clearance also express, the T cell immunoglobulin 
domain mucin domain protein 4 receptor (TIM4) and the TAM receptors (Tyro2, Axland 
Mer) which bind to Gas 6 both are expressed by neurons (Lemke and Rothlin 2008). These 
receptors regulate the effects of TLR mediated response by inducing the expression of 
Suppressor of Cytokine Signalling proteins (SOCS 1 and 3), a family of intracellular 
inducible proteins, that inhibit cytokine synthesis. (Baker et al., 2009).  
8.2 Neuroimmunoregulatory molecules (NIRegs) regulate the innate immune response 
and prevents inappropriate activation 
One basic property of the NIRegs is their expression by host cells, but neither by pathogens 
nor by apoptotic cells. NIRegs interact with either macrophages or microglia to provide 
immuno regulation, promoting a reduction in the severity of inflammation and facilitating 
tissue repair (Hoarau et al., 2011).  
Examples of NIRegs, include CD200 and CD47; these two molecules both represent “don’t 
eat me” signals cells, to prevent un warranted phagocytosis, whereas the Siglecs detect sialic 
acid (a “don’t eat me” signal) on host cells resulting in immuno regulation and inhibition of 
microglial activation. CRProteins modulate complement activation whereas, the the 
CD24/siglec 10 pathway inhibits DAMPs initiated inflammatory response (Chen et al., 
2009). see table 2, for a summary of the current NIreg s.  
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8.3 Complement regulatory proteins (CRP) as NIRegs 
To avoid self-destruction, host cells employ a range of regulatory molecules, including the 
CRP, which inhibit assembly of either the C3-cleaving enzymes or the formation of the 
membrane attack complex (MAC) on host cell surface. As pathogens lack these inhibitors, 
activation of the complement cascade can proceed and results in lysis or phagocytosis of 
microbial intruders. (Zipfle and Skerka 2009). However, animals deficient in CRP are also 
likely to experience severe inflammation, because unregulated activation of the C system 
will generate C3a and C5a, both anaphylatoxins(chemotaxis of macrophages and 
neutrophils) with uncontrolled activation of MAC.  
Similarly, as “self” cells progress to “altered self” (apoptotic cells), there is a down-
regulation of complement inhibitors (including CRP) at the cell surface including a low sialic 
acid content and the loss of the CRP, FH(Crocker and Verki 2001). The loss of CRP based 
membrane inhibitors, such as CD46, can lead to moderate and limited opsinonisation of 
apoptotic cells with the complement proteins (C3b, iC3b) with the promotion of 
phagocytosis by CR3/CR4. (Elward et al., 2005) 
The soluble C1 inhibitor (C1-INH), C4b-binding protein (C4bp), factor H (fH), factor I (fI), S 
protein (Sp) and clusterin are all CRP, expressed by glia and neurons (Gasque 2004). C4bp is 
an important NIReg, because it is able to inhibit the DAMP effect of DNA released from 
necrotic cells and has been detected upon amyloid plaques in AD, potentially limiting C 
activation (Torouw et al., 2007; Torouw et al., 2005).  
The other CRP are expressed on the cell membrane and include two trans membrane 
proteins CR1, membrane cofactor protein (MCP, CD46) and two GPI-anchored proteins, 
Decay Accelerating Factor (DAF, CD55) and CD59 (see comprehensive review Zipel and 
Skerka., 2009). Moreover, since CD55 is a ligand for CD97 on macrophages it is tantalizing to 
speculate that CD55-CD97 interactions could play an important role regulating phagocytosis 
(Hamann et al., 1996).  
FH, CD55 and CD59, fulfill the criteria for an NIReg given that they are broadly expressed 
and extremely important in the control of complement activation on self-cells. Neurons also 
express NIRegs in the form of the CRP, Factor H. This CRP is able to reduce axonal 
degeneration (self injury) in a MOG induced EAE model, as the result of inhibiting C 
pathway activation. (Griffiths et al., 2009) 
8.4 Siglecs are an emerging NIReg 
The Siglecs, are expressed by monocytes, microglia and macrophages; they have a 
potentially important immuno regulatory function in the CNS (Linnartz et al., 2010) The 
absence of sialic acid expression on micro-organsims or apoptotic cells is detected by siglecs 
as a signal of “missing self “and this promotes phagocytosis (Crocker and Virki 2001). To 
emphasize the importance of sialic acid residues as a signal of “self”, over twenty, 
pathogens have evolved the capacity to synthesize or capture sialic acids, providing 
molecular mimics of host (“self “) and thus avoiding detection by their host (Jones et al., 
2003). This possibility is supported by evidence showing Group B Streptocci with siaylated 
surface molecules bind to neutrophils expressing siglec 9, with reduction in their killing 
response aiding the survival of bacteria (CaoCrocker 2010).  
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The CD33 related sub-family of Siglecs (includes human Siglec 10, Siglec 11, Siglec 16) and 
the CD22 related Siglecs, both signal through cytosolic ITIM (immuno receptor tyrosine 
based inhibitory motifs) that provide inhibitory regulation of receptor pathways (Crocker 
and Varki 2003; Lemke and Rothlin 2008). This association strengths the potential NIReg 
regulatory role for both CD33 and CD22 siglecs on the basis of their capacity to detect 
sialylated glycans (-2, 6 2, 3 and 2, 8 linked sialic acids) representing markers of” self 
“on host cells.  
The interaction between CD22 and B cells results in a phosphorylation of ITIMS with the 
recruitment of the Src homology 2 domain –containing protein tyrosine phophatases(SHP-1 
and SHP-2 proteins) with a down regulation of inflammatory signalling. (Crocker 2007).  
Cortical neurons express high levels of CD 22 and on ligation with microglial CD45 it 
reduced LPS induced microglial expression of TNF–acting as a negative regulator of 
microglial cytokine release (Mott et al., 2004). Siglec 11, expressing microglia have a reduced 
neurotoxic capacity and fail to phagocytose apoptotic material in micro glial- neuron co 
culture experiments. (Wang et al., 2010: Toguchi et al 2009).  
CD33 related Siglecs inhibit cell proliferation, negatively regulate TLR, increase apoptosis 
and reduce IFN production, again through ITIM signalling pathways (Cao and Crocker 
2010). The absence of sialic acid in the cell wall of a pathogen will prevent the interaction 
with CD22, CD33, resulting in the failure to promote an ITIM related inhibitory response 
with an increased host “ protective “ inflammatory response (Crocker 2010). The presence of 
sialic acid residues defines host cell as “self” and initiates an inhibitory signal to down 
regulate any inflammatory response and prevent inappropriate phagocytosis of host cells. A 
further immunoregulatory role for Siglecs is their inhibitory response to TLR signalling 
activated by DAMPs.  
8.5 CD24/siglec 10; an NIReg pathway that regulates DAMPS and reduces tissue 
injury 
The successful resolution of pathogen invasion of the CNS requires the detection of PAMPs 
and also DAMPs released by tissue injury. HMBG, S100 and HSP are all examples of a 
DAMPand released from cells after injury. The innate immune system can be activated by 
DAMPs as a consequence of being detected by a RAGE and TLRs and triggering the TLR –
MyD88 –NFkB pathway (Liu et al., 2009). Of interest, is the relatively low level 
inflammatory response elicted by DAMPs, raising the possibility that DAMPS are capable of 
regulating the inflammatory response.  
One pathway, capable of imunoregulating DAMPS involves, CD24, a heat stable antigen 
and GPI anchored protein, that binds to HMBG, reducing the pro inflammatory properties 
of this DAMP. Two lines of evidence support the regulatory role of CD24; individuals with 
polymorphisms of CD24 appear to at risk of developing so called autoimune disease 
involving inflammation and when T cells are introduced into CD24 deficient mice, they 
undergo rapid proliferation. Furthermore CD24, is expressed in the developing CNS and by 
stem cells; although not fully characterized, it is known to regulate cell proliferation and 
neuritic outgrowth (Kleene et al., 2001: Shewan et al., 1996).  
CD24 detect s DAMPs, but not PAMPS and the CD24- DAMP complex binds to the Siglec 
10, which has an ITIM motif and recruits SHP-1 SHP-2 and SHIP complexes. The presence of 
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Siglec 10- SHIP-1 compex inhibits the DAMP-TLR /NLR based activation of the NF-kB 
pathway, reducing DAMP activated inflammatory cytokine expression. PAMP activation of 
the TLR –MyD88 –Nf-kB pathway remains intact and inflammatory cytokines are 
synthesised. This proposed pathway, based upon CD24 binding to DAMPS, but not PAMPS, 
allows the host to regulate endogenous protein activation of inflammation following 
infection and neuro degeneration, adding a further protective pathway to reduce the 
severity of tissue injury.  
Mice deficient in the human homologue of siglec 10 have an increased proinflammatory 
response to pathogens (Chen et al., 2009). Further evidence, that the CD24/siglec 10 
interaction presents an NIReg pathway is the inhibition of the inflammatory response 
initiated by the DAMPS, HSP 70 and HSP90 (Liu et al., 2009). The CD24 /Siglec 10 pathway 
represent an NIReg pathway capable of regulating endogenous DAMPs released during 
injury, neurodegeneration and infection. (Liu et al 2009; Hoarau et al., 20011) 
8.6 CD200-200R an NIReg pathway for evasion of phagocytosis 
CD200, is a well defined member of the NIRegs family it is expressed by reactive astrocytes; 
its counter receptor, C200R is expressed by microglia and perivascular macrophages 
(Barclay et al., 2002; Broderick et al., 2002 Lyons et al., 2007). The interaction between CD200 
and CD200R results in down regulation of microglial phagcocytosis, preventing “self” attack 
(Barclay et al., 2002: Hoek et al., 2000). CD200 is a 41-47kD surface molecule and a member 
of the immunoglobulin Ig supergene family, characterized by two IgSF domains (Barclay et 
al., 2002; Wright et al., 2001). It is a highly conserved and found in invertebrates and 
vertebrates; like many of the glycoproteins containing this molecular arrangement they are 
involved with regulation of the immune system.  
In the brain CD200, is expressed by microglia, cerebellar and retinal neurons, together with 
vascular endothelium. (Broderick et al., 2002). The counter receptor to CD200, CD200R, also 
contains two IgSF domains and is expressed by myeloid cells and brain microglia (Koning et 
al., 2009; Koning et al., 2007). In CD200 deficient mice, the number of activated microglia 
and macrophages were more numerous after an experimental lesion, as compared to wild 
type animals, providing evidence that the CD200/CD200R interaction is related to 
regulation of microglial activation and regulation of local inflammation (Hoek et al., 2000). 
This interpretation is supported by experiments in CD200 -/-mice inoculated with myelin 
oligodendrocyte glycoprotein MOG peptide to induce EAE. In these experiments the 
severity of the EAE was increased owing to the loss of CD200 regulation of microglial 
activity (Hoeket al., 2000). The contribution made by the CD200 (astrocytes)-CD200R 
(microglia) interaction on microglia in MS and AD remains to be established, although 
evidence for a dysregulation of CD200-CD200R pathway as a contributory factor to increase 
the severity of inflammation in MS has been proposed (Koning et al., 2009).  
8.7 CD47-C172 an NIReg pathway as a marker of “ self” or “don’t eat me”.  
CD47, is expressed by astrocytes, neurons, macrophages and endothelium. The interaction 
between CD47 with the counter receptor CD172a, down regulates microglial activity, 
complement activation and cytokine expression, overall reducing the severity of the 
inflammatory response (deVries et al., 2002 Reinholdet al., 1995) 
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CD47 has five trans membrane regions with alternatively spliced isoforms of CD47 having a 
tissue specific expression, form 2 is present in bone marrow, whereas form 4 is highly 
expressed in brain (Reinhold et al., 1995). CD47, has two counter receptors; CD172a is 
expressed by myeloid cells, microglia and neurons a plasma membrane protein with three 
Ig domains in its extracellular component (Brown et al., 2001) and thrombospondin TSP 
(Lamy et al., 2007).  
The interaction between CD47 with CD172a, recruits tyrosine phosphotases SHP-1 and SHP-
2, with down regulation of macrophage phagocytosis, complement activation and cytokine 
synthesis including (Vernon –Wilson et al 2001: Brown et al., 2001: Oldenborg et al., 2001: 
Seiffertet al., 2001. The protective activity of CD47 could also be extended to its beneficial 
role in supporting neural development and promoting clearance of amyloid fibrils, albeit by 
mechanisms that remain ill-characterized (Bamberger et al., 2003).  
The interaction between CD47 and CD172a has been shown to reduce neutrophil migration 
across endothelium and blocking CD47 induced expression of inflammatory cytokines by 
dendritic cells. CD47 is capable of inducing apoptosis in both T cells and cells deficient in 
CD47 i. e. loss of “self” identity, these cells are subsequently cleared rapidly from the 
systemic circulation by the spleen. (Oldenborg et al., 2001). The interaction between CD47 
and thrombospondin promotes apoptosis of activated T cells, therefore, reducing 
inflammation by terminating T cell activation (Lamy et al., 2007: Sarati et al., 2008).  
Hence, CD47, represents an important “don’t eat me signal”, preventing inappropriate 
phagocytosis of host cells (Elward and Gasque 2003). Apoptotic cells rapidly loose CD47, 
reducing its ability to bind and phosphorylate CD172a to recruit inhibitory signals and 
increasing their clearance through phagocytosis. The presence of CD47 on neurons and T 
cells is capable of promoting apoptosis through the CD95/Fas and caspase independent 
pathways (Manna et al., 2005). In MS, CD47, but not CD172a expression, is reduced at the 
edge of a chronic plaque, contributing to the loss of immuno regulation of microglia in this 
chronic inflammatory disease(Koning et al 2009).  
The finding that viable cells are readily ingested if ‘don’t eat me signals’ are disrupted raises 
the intriguing possibility that recognition and removal by phagocytosis is a default process 
that is actively prevented by inhibitory ligands on viable cells. Whether or not the CD47-
CD172a pathway is capable of regulating microglial activity in disease remains to be 
determined. (Hoarau et al., 2011) 
9. Emerging NIRegs; semaphorins and suppressor of cytokine signalling 
proteins (SOCS) 
9.1 Semaphorins and microglia represent a potential pathway to regulate the host 
inflammatory response 
The semaphorins are a diverse group of highly conserved trans membrane and extra cellular 
proteins with an extra cellular, 500 amino acid cysteine rich, semaphorine domains. 
Semaphorins bind to a diverse range of receptors; in the brain, plexins and neuropilins 
whereas in the immune system, the C -type lectin, CD72 is expressed mainly by T cells, but 
also on DC and macrophages. The functional importance of the semaphorins was initially 
directed towards control of axon growth, but it is now apparent these molecules are 
important immuno regulators in the CNS (Takegahara et al., 2005).  
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The interaction between Sema 4D (originally CD100), a trans membrane semaphorine, and 
the immune system CD72 results in an increased expression of cytokines by B cells, because 
Sema 4D turns off the inhibitory ITIM associated pathway (Suzuki et al., 2008). In the CNS 
microglia are activated by Sema 4D binding to plexin B1, rather than the CD72 molecule that 
is also expressed by microglia (Okuno et al; 2009) 
Interestingly, plexin B1 and Sema 4D deficient mice are resistant to EAE induced by MOG 
derived peptide, because of the failure to generate MOG –specific T cells, emphasising the 
importance of functional Sema 4D for T cell activation and differentiation within the CNS 
(Takegahara et al., 2005). Antibodies raised against Sema 4D reduced inflammation during 
EAE, this was explained as the result of blocking T cells expressing Sema 4D interacting 
with microglial plexin to promote expression of pro inflammatory cytokines (Okuno et al., 
2009).  
In contrast to the other NIReg pathways, Sema 4D, increases the host inflammatory 
response by upregulating the level of cytokine expression and microglial activation. The 
regulation provided by Sema4D ensures the host inflammatory response is approporiate to 
counter the effects of pathogens and neurtoxic proteins. Conversly inhibition of the SEMA 
4D-plexin pathway represents a potential new target to suppress and regulate neuro 
inflammation.  
9.2 Suppressor of cytokine signalling proteins (SOCS) 
SOCS, are a family of eight intracellular, cytokine inducible proteins, expressed by CNS cells 
(microglia, astrocytes and neurons) that inhibit IFN signalling in CNS cells (Baker etal., 
2010). Through activation of STAT transcription factors the C terminal of the SOCS binds to 
and inhibits phosphorylated tyrosine residues on Janus kinases (JAK), in addition the of the 
N terminus contains a kinase inhibitory region, and this also inhibits INF synthesis and 
blocks the NF-kB pathway. In the brain, SOCS1 and 3 are induced by a variety of 
inflammatory cytokines including INFand LPS. Overall, SOCS 1and 3 are examples of 
NIRegs because they block the JAK/STAT pathway regulating glial and neuron 
inflammatory cytokine synthesis.  
SOCS1 and SOCS3 have potentially important clinical applications. Administration of SOCS-1 
to experimental animals prevents EAE by inhibiting JAK-2 mediated phosphorylation 
reducing the expression of inflammatory cytokines IL-2, IL -5 and TNF raising the possibility 
that SOCS-1 is a potential therapeutic agent to treat inflammatory mediated demyelination 
(Baker et al 2010)Furthermore, the level of SOCS 3 exppressed by T cells in relapsed MS was 
less than in remission and this correlated with STAT levels, such that reduced SOCS allowed 
STAT to rise increasing inflammatory cytokine levels and increasing the likelihood of relapse. 
(Baker et al 2009 for review of clinical studies involving SOCS) 
9.3 Loss of immuno surveillance, NIRegs and CNS neoplasia 
Glioblastoma (GBM), is the most common primary brain tumour in adults, it is highly 
aggressive and infiltrates throughout the brain. These tumours have developed the capacity 
to escape immune surveillance by suppressing the host anti -glioma response. Failure to 
promote an anti glioma response is associated with an accumulation of immunosuppressive, 
CD4-Fox P3+ regulatory T cells, both within and surrounding the tumour (Sonabend et al., 
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2008). Glioma stem cells and macrophages are also capable of inducing immuno supression 
in host microglia, because they express the anti -inflammatory cytokines TGF-1 MIC-
1macrophage inhibitory factor and also inhibit microglial phagocytosis (Wu et al., 2010; 
Hussain et al., 2006). A pivotal role in this apparent loss of anti- glioma response is the 
inhibition of the JAK/STAT signalling pathway in glioma cells with resulting cell 
proliferation, inhibition of both host cell inflammatory response and tumour immuno 
surveillance (Brantley et al., 2008). The inhibition of STAT signalling pathway in GBM is 
thought to result from an over expression of the NIReg, SOCS -1that inhibits STAT and 
function as an immuno-modulatory molecule by blocking IFN┚ and CD40, with the down 
regulation of both MHC I and II expression in GBM. However, the function role of the other 
SOCS proteins (SCOCS- 3) in GBM remains to be clarified; in vitro SOCS -3 increases the IL-
10 mediated anti-inflammatory response and radio resistance, but therapeutic inhibition of 
STATalso promotes microglial recognition of glioma cells (Baker et al., 2009).  
Glioma cells express a limited range of TLR and application of various ligands including 
LPS and Poly I; C did not have any therapeutic effect, probably due to the failure to 
stimulate intra tumour Antigen Presenting Cells. (Grauner et al., 2008. However, the 
injection of the TLR9 ligand,  CpG, an oligonucleotide, resulted in effective anti glioma 
response with inhibition of local Tregs,  together with an T effector cell mediated anti -
glioma respons. TLR9 is not present in host cells surrounding the glioma, providing an 
explanation for the apparent failure of host cell to produce an effective T cell response 
(Grauner et al., 2008). The intra tumour injection of ligands such as CpG to selectively 
stimulate host expression of TLR is of potential therapeutic importance.  
One further protective strategy employed by gliomas to evade imuno surveillance is the 
expression of C regulator proteins. Activation of C pathway is potentially able to lyse 
tumour cells, but several glioma cells lines have been shown to express complement 
regulators CD59, CD55, CD46 and FH on their cell surface, preventing C attack and 
generation of lytic MAC(Maenpaa A et al., 1996, Junnikkala S et al., 2000). One possible 
therapeutic route is infact, the use of surface CD46, this Creg is very similar to the 
adenovirus receptors (adenovirus serotype 3) and provides a target to deliver an adenovirus 
containing anti- glioma therapy. (Ulasov et al 2006) 
Outside the CNS, squamous cell carcinoma of the skin, leukaemias and myeloma cells up 
regulate surface expression of the NIReg, CD200, and this inhibits local immune detection 
promoting metastatic potential. After spreading to local lymph nodes, metastatic tumour 
cells that are CD200+ interact with local CD200R+ myeloid drived cells such as 
macrophages and potentially microglia, enhancing their survival, conversely loss of CD200 
reduces metastatic tumour survival. The expression of CD200 is a property of the primary 
tumour and this expression did not vary according the type of tissue infiltrated by 
metastatic tumour (Stumpova et al., 2010).  
10. Conclusion 
The host inflammatory reaction is required to counter the detrimental effects of pathogen 
invasion (encephalitis and meningitis) and the accumulation of amyloid, mutant prions 
(neurodegenerative disease). One consequence of the host’s protective inflammatory 
reaction is an inevitable amount of associated tissue injury. The detrimental effects of tissue 
www.intechopen.com
 
Recent Advances in Immunology to Target Cancer, Inflammation and Infections 
 
222 
injury have to be to be balanced against the, consequences of not removing a pathogen (or 
clearing neurotoxic proteins), usually this leads to peristent inflammation preventing any 
tissue repair. This balance between protective and destructive consquences is the so called 
“double edged sword”effect, that accompanies brain inflammation (Wyss- Coray and 
Mucke 2002). The role of the NIRegs is to modulate the level of the protective inflammatory 
response, in order to provide the “appropriate amount “ of inflammation to allow the 
efficent clearance of pathogens and neurotoxic proteins from the brain.  
The immune response against “non self” (pathogens, neurotoxic protiens) must be critically 
regulated in order to provide conditions of tissue repair without excessive destruction of “self 
“or host cells. Self (host) must be distinguish from “ non –self “as defined by, pathogens 
PAMPs, apoptotic cells ACAMPs and “danger proteins” (HMGB1, HSP and S100) classified as 
(DAMPs). Non self (PAMPS, DAMPS), is detected by a range of intracellular and trans 
membrane PRR (TLR, RIG, NDLR,) whereas the scavenger receptors CD14, CD36, C lectins 
and TREM-2 provide a clerance pathway for apoptotic cells and neurotoxic proteins. 
Activation of the complement pathway by pathogens and neurotoxic proteins (Fibrillary 
Amyloid and mutant prion protein) results in MAC formation and anaphylotoxins C3a and 
C5a, all promoting inflammation and tissue destruction. The C pathway also assists the SR 
clear apoptotic cells through opsonins C3 and C4 localization on the surface of apoptotic cells.  
To prevent excessive host tissue destruction, (NIRegs) must control the proinflammatory 
response and efficiently clear apoptotic cells (non-phlogistic response), before they are able to 
release neurotoxic enzymes to increase host tissue destruction. NIRegs, provide cell surface 
signals (CD200, CD47, sialic acid, CD46,) to identify “self “ and through interaction with 
counter receptors (CD200R, CD172a, FH, Siglecs, CD24 –Siglec,) utilizing ITAM /ITIM 
pathways, inhibit microglial activation and phagocytosis of host cells. The C pathway is 
regulated by a series of CRP also regarded as NIRegs, because they reduce C activation and 
excessive host tissue destruction. The inhibiton of CRPs on tumour cells could provide a 
mechanism to increase host anti -tumour cell lysis as well as providing receptors for the 
delivery of viruses carrying anti glioma reagents. One emerging pathway controls, microglial 
activation as the result of T cells expressing Sema 4D; inhibiton of this pathway resulted in a 
down regulation of the severity of inflammation in MOG induced EAE. Similarly, the 
contribution made by the SOCS family of intracellular proteins to regulating the innate 
immune response in a diverse range of neuroinflammatory conditions requires clarification.  
The therapeutic benefit of NIRegs is apparent, but to date, there is only limited evidence for 
their influence in clinical examples of neuro-degneration and neuro-inflammation. CD200-
CD200R, CD47 and SOCS have been detected in MS tissue providing evidence for dys 
regulation of the host inflammatory response. There is some experimental evidence to show 
PAMPS and DAMPs can be distinguished by the host and DAMP initiated inflammation is 
regulated by the emerging NIReg, CD24/Siglec, pathway. The cellular localization and 
functional importance for each of the NIRegs is summarised in table 2.  
It is highly likely the NIRegs provide a range of potentially important therapeutic reagents 
that selectively regulate the host immune response and promote tissue repair in a variety of 
brain infections (viral and bacterial), neurodegerative diseases and neoplasia. The 
opportunity presented by the NIRegs as the means to selectively regulate the CNS immune 
response to a wide range of pathogens and neurotoxic proteins should be exploited as a 
matter of some importance.   
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Pattern 
Recognition 
Receptor 
PRR 
Ligand detected PRR and CNS cell 
expression  
Function  Host Innate immune 
response  
TLR2 Bacterial cell wall 
peptidoglycan 
Zymosan (Fungi) 
Haemagluttin 
(Measles virus) 
Microglia 
Astrocytes 
 
Choroid plexus  
 
Form hetero dimres 
with TLR-1 to detect 
Gram neg ative 
bacteria 
 
Co operates with 
Dectin -1to detect 
fungi  
Microglia increased pro 
inflammatory cytokines 
Phagocytosis  
TLR3 ds RNA Neurons 
microglia 
astrocytes 
oligodendroglia  
 
West Nile Virus 
 
Detect necrosis and 
danger signals 
(HMGB, HSP) 
Microglial IFNTNF 
IL-6 
 
Systemic cytokines and 
BBB receptor 
 
 
TLR4 
 Bacteria 
Lipopolysacahride 
LPS  
Microglia, 
astrocytes 
ependyma 
 
 
Choroid plexus  
Cooperates with 
CD36, CD14 and DC-
SIGN to detect fungi 
and Streptococcus 
pneumonia 
 
Microglia and astrocyte 
inflammatory cytokines 
phagocytosis of 
apoptotic cells  
TLR 5 
 
Flagellin, bacterial 
protein  
 
Macrophage 
  
TLR7 ssRNA Microglia, 
astrocytes 
ependyma, 
neurons  
 
Influenza A 
 
Detect necrosis and 
“danger signal 
“HMGB, HSP 
Astrocytes increased 
TNF IFN MCP-1 
TLR8 ssRNA Neurons   
RNA viruses  
Astrocytes increased 
TNF IFN,  
 MCP-1 
TLR9 
 
 
 
 
CpG DNA Microglia, 
astrocytes  
 
Detect necrosis and 
“danger signals” 
HMBG-1 
Microglia express TNF 
IL-12, NO 
 
HMBG-1 /RAGE 
detected by TLR-9 
TLR11 
 
 
Profilin, bacterial 
protein  
Genitourinary 
Neurons  
Detects Toxoplasmosis 
Neurocysticerosis  
Inflammatory cytokines  
RIG-1 Short dsRNA Microglia, 
astrocytes 
Japanese encephalitis 
virus 
 Influenza A, Ebola 
virus  
Astrocytes express IFN, 
IL-6, IL-8 RANTES 
 
MDA-5  
 
Long dsRNA  
 
Microglia 
astrocytes 
 
?Nipah virus, polio 
virus,  
 
Microglia express IFN 
NOD like Bacterial cell wall   Listeria bacillius Shigella   
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Receptors 
NOD-1 and 
NOD-2  
?Microglia, 
astrocytes  
Flexneri 
Helicobacter pylori 
Mycobacterium 
tuberculosis  
NLR -3 
(NLP-3) 
 
Bacterial cell wall 
peptidglycan 
 
peptidoglycan 
and virus proteins  
? in CNS  Bacteria 
 
Viruses 
 
Crohn’s disease  
Inflammasome(NLR 
ASC, procaspase -1) is 
engaged to produce 
inflammatory cytokines  
Table 1. Shows the individual ligands detected by TLR and Non- TLR (R LR MDA and 
NLR), Pattern Recognition Receptors PRR in the CNS. The cellular distribution of each of 
these receptors in the CNS is provided together with their contribution to host CNS innate 
immune system in response to pathogens(PAMPS and danger signals (DAMPS).  
 
Neuroimmuoregulatory 
(NIReg) 
NIReg-
receptor/ligand  
Cell –cell 
interaction  
Mechanism of 
immune 
regulation  
Human disease  
     
CD200 
Astrocyte  
CD200R 
microglia  
Astrocyte –
microglia  
Reduce 
phagocytosis  
Alzheimer’s (AD) 
Multiple sclerosis (MS) 
CD47 
 Astrocyte 
 Endothelium neuron 
CD172a 
myeloid cells    
microglia  
 Astrocyte –
microglia 
Reduce 
phagocytosis and 
cytokine 
expression  
Multiple sclerosis  
Complement regulators 
FH, CD46, CD55, CD59 
 
C4bp 
 
CD46 (MCP) 
CD55(DAF) 
 
Sialic acid 
Complement 
proteins  
 
 
Astrocytes 
 
Microglia 
 
Neurons  
Reduce C 
activation  
Neurodegenerative 
disease 
AD 
Huntington’s disease 
 
Inhibits complement 
regulation of glioma 
lysis  
Siglecs 
CD33 family 
Siglec 10 
Siglec 11 
 
 
Sialic acid 
 
Detect absence of 
sialic acids 
” non self” 
 
 
 
NK cells 
Microglia  
 
 
Reduces 
inflammation 
ITIM pathway  
 
Bacterial infection; 
bacteria mimic sialic 
acids to become “ self “ 
 
 
CD24 -Siglec 10 pathway  
DAMPs 
 
HMGB-1 
microglia 
stem cells  
Binds with SHP -
1, this complex 
inhibits DAMPS 
activation of NF-
kB  
Reduces DAMP 
associated 
inflammation 
Polymorphisms in 
CD24 associated with 
autoimmune disease  
Suppressor of cytokine 
synthesis 
SOCS1 SOCS3 
 
Inhibits IFN and IL 
cytokine 
stimulation of 
cytokine expression 
 
 
Microglia 
astrocytes 
neurons  
 
Blocks JAK/STAT 
cytokine pathway 
 
Glioblastoma SOCS 
increased 
 
SOCS reduced in 
relapsed MS 
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Thrombomodulin CD141 HMBG1/ DAMPS Microglia  Blocks HMBG 
binding to RAGE 
and TLR 
activation  
 
Semaphorin 
SEMA4 
CD72 on T cells 
 
Plexin B1 on 
microglia  
T cell with 
microglia  
Blocks ITIM 
increases cytokine 
expression  
Sema4D deficiency 
reduced EAE severity  
     
Table 2. The potential of NIRegs and their cellular localization, ligands and mechanism 
whereby they produce immuno regulation. In the final column there is information relating 
to their contribution to infection, neurodegeneration and neuro inflammation as well as 
neoplasia, in the human CNS.  
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